Company insight
OPITAC L-Glutathione for wellness and longevity
As consumers increasingly seek effective solutions for healthy ageing, demand for scientifically validated ingredients in supplements continues to grow. OPITACTM
L-Glutathione, developed by
Mitsubishi Corporation Life Sciences Europe, is a cutting-edge, clinically supported ingredient that addresses these needs. Offering proven benefits and a high bioavailability and absorption rate, it stands out as a versatile solution for modern health and wellness products.
L
-Glutathione’s antioxidant activity plays an important role in neutralising free radicals. As L-Glutathione levels decrease with age, supplementation becomes crucial for health and vitality (1). However, the advantages do not stop here. OPITACTM
L-Glutathione is set
apart by its clinical research, for example regarding its role in skin brightness. A recent study among Asian women showed a reduction in melanin production and a minimising of UV-induced
pigmentation by using 500 mg of OPITAC L-Glutathione daily (2,3). Additionally, another study showed initial results on its ability to support the liver, a key organ involved in clearing the body of toxic compounds (4). These benefits were demonstrated at doses between 100-500mg of glutathione per day, making OPITAC an efficient and effective choice.
Unlocking the benefits of OPITAC L-Glutathione
These benefits, together with its purity,
high bioavailability, and studied absorption (5), make OPITAC L-Glutathione a versatile ingredient for health supplements. Its antioxidant activity, potential liver- supporting abilities, and benefits for skin brightness align with the growing consumer interest in wellness and longevity, meeting the demand for high- quality, science-backed ingredients. ●
References available on request.
www.mclseurope.com
24639 MCLS Ingredients Insight Adv. Opitac
v3.indd 1 Ingredients Insight /
www.ingredients-insight.com
07-10-2024 09:26 27
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110
